Rodger Novak, Chief Executive Officer at CRISPR Therapeutics AG (CRSP), sold 58,103 shares at $20.31 ($1.2M) on 2017-08-30, disclosed to the SEC on 2017-08-30.
Open-market sale of $1.2M CRSP by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |